4//SEC Filing
Lingamneni Anila 4
Accession 0001127602-22-015366
CIK 0000313143other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:12 PM ET
Size
5.0 KB
Accession
0001127602-22-015366
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Sale
Common Stock
2022-05-19$59.10/sh−1,384$81,794→ 17,322 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2019 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This number includes unvested RSUs previously reported.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001808414
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:12 PM ET
- Size
- 5.0 KB